Dacomitinib (Standard)
Dacomitinib (Standard) is the analytical standard of Dacomitinib. This product is intended for research and analytical applications. Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC50s of 6 nM, 45.7 nM and 73.7 nM for EGFR, ERBB2, and ERBB4, respectively[1].
Product Specifications
CAS Number
1110813-31-4
Product Name Alternative
PF-00299804 (Standard) ; PF-299804 (Standard)
UNSPSC
12352005
Target
Apoptosis; EGFR; Reference Standards
Type
Reference Standards
Related Pathways
Apoptosis; JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dacomitinib-standard.html
Smiles
O=C(/C=C/CN1CCCCC1)NC2=CC3=C(C=C2OC)N=CN=C3NC4=CC=C(C(Cl)=C4)F
Molecular Formula
C24H25ClFN5O2
Molecular Weight
469.94
References & Citations
[1]Engelman JA, et al. PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to ZD1839. Cancer Res. 2007 Dec 15;67 (24) :11924-32.|[2]Kalous O, et al. Dacomitinib (PF-00299804), an irreversible Pan-HER inhibitor, inhibits proliferation of HER2-amplified breast cancer cell lines resistant to Anti-Human HER2 and GW572016. Mol Cancer Ther. 2012 Sep;11 (9) :1978-87.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882511-500 1x 500 µL
CD68 (Macrophage Marker) (C68/2511), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC041688-100 1x 100 µL
CD79a (IGA/1688R), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details